Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed or Refractory Advanced Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04407741
What this trial is testing

Phase Ⅰ/Ⅱ Study of SHR2554 in Combination With SHR1701 in Patients With Advanced Solid Tumors and B-cell Lymphomas

Who this might be right for
Solid TumorLymphoma
Chinese PLA General Hospital 100
Early research (Phase 1)Study completedNCT04944888
What this trial is testing

GSL Synthetase Inhibitor in Combination With Immune Checkpoint Inhibitor in Previously Treated Blood and Solid Tumor

Who this might be right for
Solid TumorHematologic Malignancy
Chinese PLA General Hospital 31
Large-scale testing (Phase 3)Study completedNCT00863746
What this trial is testing

A 3rd/4th Line Placebo-controlled Trial of Sorafenib in Patients With Predominantly Non Squamous Non-Small Cell Lung Cancer (NSCLC).

Who this might be right for
CarcinomaNon-Small-Cell Lung
Bayer 703
Testing effectiveness (Phase 2)Study completedNCT01743482
What this trial is testing

Pazopanib in Advanced and Cisplatin-resistant Germ Cell Tumors

Who this might be right for
Germ Cell TumorsMeasurable Disease
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 43
Early research (Phase 1)Study completedNCT00098826
What this trial is testing

SB-715992 in Treating Patients With Acute Leukemia, Chronic Myelogenous Leukemia, or Advanced Myelodysplastic Syndromes

Who this might be right for
Acute Undifferentiated LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)+24 more
National Cancer Institute (NCI) 40
Early research (Phase 1)UnknownNCT04975204
What this trial is testing

A Clinical Trial of TQB3909 Tablets in Subjects With Advanced Malignant Tumors

Who this might be right for
Advanced Malignant Tumor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 126
Testing effectiveness (Phase 2)Active Not RecruitingNCT04725474
What this trial is testing

First-in-Human Study of the GDF-15 Neutralizing Antibody Visugromab (CTL-002) in Patients With Advanced Cancer (GDFATHER)

Who this might be right for
Solid Tumor, Adult
CatalYm GmbH 199
Early research (Phase 1)Study completedNCT01457417
What this trial is testing

DKN-01 in Multiple Myeloma or Advanced Solid Tumors

Who this might be right for
Multiple MyelomaSolid TumorsNon-Small Cell Lung Cancer
Leap Therapeutics, Inc. 32
Early research (Phase 1)Study completedNCT01684150
What this trial is testing

A Phase 1, Open-Label, Dose-Escalation & Expanded Cohort, Continuous IV Infusion, Multi-center Study of the Safety, Tolerability,PK & PD of EPZ-5676 in Treatment Relapsed/Refractory Patients With Leukemias Involving

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndrome+1 more
Epizyme, Inc. 51
Early research (Phase 1)UnknownNCT04739293
What this trial is testing

Study of ON 123300 in Patients With Advanced Cancer

Who this might be right for
Solid Tumors, Adult
Traws Pharma, Inc. 36
Early research (Phase 1)Looking for participantsNCT07444268
What this trial is testing

How [14C]-DSP-5336 is Absorbed, Broken Down, and Removed From the Body After a Single Oral Dose in Patients With Advanced Blood Cancers

Who this might be right for
Advanced Hematologic Malignancies
Sumitomo Pharma America, Inc. 8
Testing effectiveness (Phase 2)Ended earlyNCT02213133
What this trial is testing

Selinexor Treatment of Advanced Relapsed/Refractory Squamous Cell Carcinomas

Who this might be right for
Squamous Cell Carcinoma
Karyopharm Therapeutics Inc 45
Testing effectiveness (Phase 2)UnknownNCT01027676
What this trial is testing

Study of Vorinostat and Gefitinib in Relapsed/ or Refractory Patients With Advanced Non-small Cell Carcinoma (NSCLC)

Who this might be right for
Non-Small-Cell Lung Carcinoma
National Cancer Center, Korea 50
Early research (Phase 1)Study completedNCT00004258
What this trial is testing

EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+5 more
Indiana University 40
Early research (Phase 1)UnknownNCT02580747
What this trial is testing

Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso

Who this might be right for
Malignant MesotheliomaPancreatic CancerOvarian Tumor+3 more
Chinese PLA General Hospital 20
Early research (Phase 1)Study completedNCT00161187
What this trial is testing

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

Who this might be right for
Cancer
University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)Study completedNCT00053287
What this trial is testing

Fludarabine/Carboplatin/Topotecan w/Thalidomide for Relapsed/Refractory AML, CML and MDS

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases
Case Comprehensive Cancer Center 42
Early research (Phase 1)Ended earlyNCT04214093
What this trial is testing

AZD0466 in Patients With Advanced Hematologic or Solid Tumors

Who this might be right for
Advanced Solid TumorsLymphomaMultiple Myeloma+1 more
AstraZeneca 9
Early research (Phase 1)Study completedNCT04798586
What this trial is testing

MAGNETISMM-2: Study of Elranatamab (PF-06863135) in Japanese Participants With Multiple Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Pfizer 4
Early research (Phase 1)Looking for participantsNCT06840886
What this trial is testing

PHST001 in Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsOvarian CancerEndometrial Cancer+2 more
Pheast Therapeutics 272
Next Page